.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India has achieved a landmark milestone in managing rare genetic conditions through the establishment of a specialized repository. The newly inaugurated Lysosomal Storage Disorders Biobank in Gujarat offers significant hope for patients seeking affordable diagnostic pathways. Consequently, this facility at the FRIGE's Institute of Human Genetics consolidates two decades of rigorous clinical research. Furthermore, the repository currently manages biological samples from more than 530 patients across the country.
The facility serves as a critical infrastructure for identifying complex genetic mutations in a resource-limited setting. By integrating DNA data with detailed clinical profiles, researchers can now accelerate the development of indigenous medical solutions. Moreover, the biobank includes serum, plasma, and genomic DNA samples to support long-term healthcare outcomes. Although treatment costs for these conditions often exceed Rs 1 crore annually, this initiative aims to lower economic barriers. Therefore, clinicians can expect improved access to cost-effective diagnostic kits in the near future.
The institute recently developed a molecular probe-based sequencing asset to streamline the identification of rare metabolic conditions. This technological advancement allows for the comprehensive diagnosis of 19 different lysosomal storage disorders simultaneously. Additionally, the Gujarat State Biotechnology Mission provided essential funding to foster this genetic innovation. Because the biobank functions as a national resource, it strengthens India's self-reliance in advanced medical research. Ultimately, these efforts position Gujarat as a primary hub for global genetic advancements.
Q1: What types of biological samples does the new biobank store?
The biobank maintains a comprehensive repository including serum, plasma, whole blood genomic DNA samples, and urine precipitates from over 530 patients.
Q2: How does the biobank impact the cost of diagnosing rare disorders?
By utilizing indigenous molecular probe-based sequencing assets, the facility significantly reduces the cost of diagnosing multiple disorders compared to traditional methods.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Gujarat launches India's first national biobank for Lysosomal Storage Disorders to provide affordable diagnosis and genetic research for rare diseases....
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
